The problems of prolonged spring oestrus in mares, which is often associated with multifollicular ovaries (MFO), are described in the context of the need to produce foals early in the year. The results obtained, in terms of pregnancy and time of ovulation, after the intramuscular administration of a single standard 15-ml (1500 mg) dose of proligestonea are described and compared with data available for allyl trenbolone, b, which is given orally, and with accepted data for non-medicated mares. It is concluded that proligestone may be useful in treating MFO and that its use may even aid conception. This latter observation is worthy of further investigation
The present study evaluated the effect of altrenogest treatment during 70 or 120 days of gestation o...
Two experiments were conducted to test the efficacy of altrenogest treatment in mares. The response ...
Thirty pregnant mares were assigned to 3 groups: Group 1 (n = 10) mares served as controls; Group 2 ...
This study took place over a 3 year period and was conducted in 4 phases. In total, 40 mares of stoc...
In its first year of commercial availability in the United States, reports from the field indicated ...
Abstract Background Strong oestrous symptoms in the mare can cause problems with racing, training an...
In our experience, altrenogest has not always been able to exert predictable control over the estrou...
Twenty-two pony mares were used in a project designed to determine the effectiveness of different tr...
Due to the character of the original source materials and the nature of batch digitization, quality ...
To date, there has been limited research on manipulation of the estrous cycle in endangered equids. ...
During the spring between anestrous and the resumption of normal cyclicity, mares experience a trans...
Progesterone or the synthetic progestin analogue altrenogest (Regumate1) is commonly used in the mar...
Graduation date: 1987Studies were conducted in order to evaluate the efficacy of the\ud orally activ...
The efficacy of melengestrol acetate (MGA) to shorten the vernal transition of mares by synchronisin...
The use of equine FSH (eFSH) for inducing follicular development and ovulation in transitional mares...
The present study evaluated the effect of altrenogest treatment during 70 or 120 days of gestation o...
Two experiments were conducted to test the efficacy of altrenogest treatment in mares. The response ...
Thirty pregnant mares were assigned to 3 groups: Group 1 (n = 10) mares served as controls; Group 2 ...
This study took place over a 3 year period and was conducted in 4 phases. In total, 40 mares of stoc...
In its first year of commercial availability in the United States, reports from the field indicated ...
Abstract Background Strong oestrous symptoms in the mare can cause problems with racing, training an...
In our experience, altrenogest has not always been able to exert predictable control over the estrou...
Twenty-two pony mares were used in a project designed to determine the effectiveness of different tr...
Due to the character of the original source materials and the nature of batch digitization, quality ...
To date, there has been limited research on manipulation of the estrous cycle in endangered equids. ...
During the spring between anestrous and the resumption of normal cyclicity, mares experience a trans...
Progesterone or the synthetic progestin analogue altrenogest (Regumate1) is commonly used in the mar...
Graduation date: 1987Studies were conducted in order to evaluate the efficacy of the\ud orally activ...
The efficacy of melengestrol acetate (MGA) to shorten the vernal transition of mares by synchronisin...
The use of equine FSH (eFSH) for inducing follicular development and ovulation in transitional mares...
The present study evaluated the effect of altrenogest treatment during 70 or 120 days of gestation o...
Two experiments were conducted to test the efficacy of altrenogest treatment in mares. The response ...
Thirty pregnant mares were assigned to 3 groups: Group 1 (n = 10) mares served as controls; Group 2 ...